Case File
efta-01779305DOJ Data Set 10OtherEFTA01779305
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-01779305
Pages
2
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From:
Giuffrida, David J
Sent:
Thursday, February 24, 2011 3:54 PM
To:
Epstein, Jeffrey ([email protected])
Cc:
Barrett, Paul S
Subject:
Trade Details
Jeffrey,
You sold to close 100 strike May 17=sup>th expiry WTI call option on 50,000 Bbl (1/2 your position) @ $7=2E90/ Bbl.
$102.40 spot reference on June WTI contract. =o:p>
=et me know if you have any questions.
&nbs=;
Thanks again.
David =. Giuffrida
J.P. =organ I Global Investment Opportunities Group=o:p>
40 West 57th Street, Floor =3
New York, NY 10019</=:p>
T:
F:
</=>
<=pan style=ifont-size:10.0pt;font-family:"Calibri","sans-serir;color:b=ack'>IRS Circular 230 Disclosure:
JPMorgan Chase=& Co. and its affiliates do not provide tax advice. Accordin=ly, any discussion of U.S. tax
matters contai=ed herein (including any attachments) is not intended or written to be use=, and cannot be used, in
connection with the promotion, marketing or recom=endation by anyone unaffiliated with JPMorgan Chase & Co. of any
of =he matters addressed herein or for the purpose of avoiding U.S. tax-re=ated penalties.
This is not an official confirm=tion.
</=pan>
EFTA_R1_00096458
EFTA01779305
T=is communication is for informational purposes only. It is not intended =s an offer or solicitation for the purchase or
sale of any financial instr=ment or as an official confirmation of any transaction. All market price=, data and other
information are not warranted as to completeness or accur=cy and are subject to change without notice. Any comments
or statements =ade herein do not necessarily reflect those of JPMorgan Chase & Co., its=subsidiaries and affiliates. This
transmission may contain in=ormation that is privileged, confidential, legally privileged, and/or exem=t from disclosure
under applicable law. If you are not the intended reci=ient, you are hereby notified that any disclosure, copying,
distribution, =r use of the information contained herein (including any reliance thereon)=is STRICTLY PROHIBITED.
Although this transmission and any attachments a=e believed to be free of any virus or other defect that might affect
any c=mputer system into which it is received and opened, it is the responsibili=y of the recipient to ensure that it is
virus free and no responsibility i= accepted by JPMorgan Chase & Co., its subsidiaries and affiliates, as a=plicable, for any
loss or damage arising in any way from its use. If yourreceived this transmission in error, please immediately contact the
sender=and destroy the material in its entirety, whether in electronic or hard co=y format. Thank you. Please refer to
http://www.jpmorgan=2Ecom/pages/disdosures for disclosures relating to European legal entitle..
2
EFTA_R1_00096459
EFTA01779306
Technical Artifacts (3)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.